Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Twist Bioscience Corporation - Common Stock (NQ:TWST)

68.74 -0.48 (-0.69%)
Streaming Delayed Price Updated: 2:14 PM EDT, Jun 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Twist Bioscience Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
News headline image
Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing
From Twist Bioscience Corporation
Via Business Wire
News headline image
Cathie Wood's Ark Invest Offloads $6.9M Worth of Coinbase, Robinhood Shares Each Amid Searing Bitcoin Rally — Nvidia Stock Also Shed ↗
On Monday, Cathie Wood-led Ark Invest adjusted its portfolio, notably selling shares of cryptocurrency-related companies such as Robinhood Markets Inc (NASDAQ:HOOD) and Coinbase Global Inc (NASDAQ: 
Via Benzinga
News headline image
Twist Bioscience to Present at Upcoming Investor Conferences
From Twist Bioscience Corporation
Via Business Wire
News headline image
4 Analysts Have This To Say About Twist Bioscience ↗
 
Via Benzinga
News headline image
Twist Bioscience Earnings Preview ↗
 
Via Benzinga
News headline image
Is The Stock Market Ready To Plunge? The Warning Signs Are Here... ↗
Find out how to spot the exhaustion of demand and the bearish analogue you could refer to to anticipate the down move. 
Via Talk Markets
News headline image
7 Stocks Cathie Wood Is Still Loading Up On in Q1 ↗
You won't find many timid bets among the Cathie Wood stocks she believes will dramatically alter our future. 
Via InvestorPlace
News headline image
7 Sexy Stocks That Will Continue to Outperform in 2024 ↗
These outperforming stocks are prime candidates for increasing in value sharply this year and beyond. Discover the top picks. 
Via InvestorPlace
News headline image
Cathie Wood Trims Nvidia, Shopify Stakes To Pump Whopping $40M Into Pinterest Despite Q4 Revenue Miss ↗
 
Via Benzinga
News headline image
Cathie Wood's Ark Invest Sheds $2.8M Worth Of Nvidia Shares Amid AI Hype, Picks Up Robinhood Stock Worth $1.3M ↗
 
Via Benzinga
Topics Artificial Intelligence
News headline image
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience and Element Biosciences Collaborate on Exome Sequencing Solutions for AVITI System
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Unveils Differentiated Ultra High-Throughput Library Preparation Solution at AGBT
From Twist Bioscience Corporation
Via Business Wire
News headline image
Why Is DNA Synthesis Company Twist Bioscience Stock Trading Higher Today? ↗
Twist Bioscience reported Q1 2024 earnings, beating revenue guidance and increasing FY24 guidance. Shares are up 7.16%. 
Via Benzinga
News headline image
Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results
From Twist Bioscience Corporation
Via Business Wire
News headline image
Earnings Scheduled For February 2, 2024 ↗
Companies Reporting Before The Bell • W.W. Grainger (NYSE:GWW) is likely to report quarterly earnings at $8.05 per share on revenue of $4.04 billion. 
Via Benzinga
News headline image
Twist Bioscience Corp Daily Investment Opportunity ↗
Twist Bioscience is a public biotechnology company founded in 2013 and it’s based in South San Francisco. It manufactures synthetic DNA and DNA products for customers in a wide range of industries. 
Via Talk Markets
News headline image
Twist Bioscience Expands Express Genes Rapid Synthesis Service
From Twist Bioscience Corporation
Via Business Wire
News headline image
Goldman Sachs Upgrades Twist Bioscience, Says Express Genes Launch Will Drive Margin Expansion ↗
Goldman Sachs upgrades Twist Bioscience as Express Genes launch addresses SynBio division's gross margin issues. With 5-7 days gene delivery, TWST taps into a previously inaccessible market, enhancing... 
Via Benzinga
News headline image
Netflix To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Wednesday ↗
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
News headline image
Twist Bioscience to Report Fiscal 2024 First Quarter Financial Results on Friday, February 2, 2024
From Twist Bioscience Corporation
Via Business Wire
News headline image
Biotech Playbook: Small Caps Show Momentum Peaking During ↗
The momentum of selected stocks was strong up until early January was encouraging but we need less volatility in period ahead to conform a new bull market. 
Via Talk Markets
News headline image
Twist Bioscience Corporation Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Appoints Adam Laponis as Chief Financial Officer
From Twist Bioscience Corporation
Via Business Wire
News headline image
3 Genomics Stocks to Unlock the Future of Medicine ↗
Genomics stocks stand to surge in 2024 after the FDA approved the nation's first gene-editing therapeutic for clinical use. 
Via InvestorPlace
News headline image
Twist Bioscience to Present at 42nd Annual J.P. Morgan Healthcare Conference
From Twist Bioscience Corporation
Via Business Wire
News headline image
Tuesday Talk: CPI Data And FOMC Meeting Hold Back Market Breakout ↗
While the market continues towards making new highs, it is falling short of making a breakout rally. Forthcoming CPI data and the upcoming FOMC meeting may be the catalyst for same. 
Via Talk Markets
News headline image
Biotech Is Coming Back, Can The Run Last? ↗
The rally can be attributed to lower interest rates and seasonal factors from the end of Q4 through January. But recently some major biopharmaceutical deals have supported the rally. 
Via Talk Markets
News headline image
Five Best Performing Stocks Of The Top ETF Of November ↗
Most stocks in ARKK’s portfolio delivered strong returns in November. These five led the way. 
Via Talk Markets
Topics ETFs
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.